Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beta-blocking drugs and myocardial function.

S H Taylor

    Journal of Cardiovascular Pharmacology
    |January 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Beta-adrenoceptor antagonists attenuate heart rate and contractility but can cause adverse effects. Newer agents, like celiprolol, offer improved hemodynamic benefits by modulating sympathoadrenal activity.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Maximal stomatal conductance to water and plasticity in stomatal traits differ between native and invasive introduced lineages of Phragmites australis in North America.

    AoB PLANTS·2016
    Same author

    Photosynthetic pathway and ecological adaptation explain stomatal trait diversity amongst grasses.

    The New phytologist·2011
    Same author

    Drought limitation of photosynthesis differs between C₃and C₄grass species in a comparative experiment.

    Plant, cell & environment·2010
    Same author

    Effects of chronic hepatitis C infection on the treatment of breast cancer patients.

    Annals of oncology : official journal of the European Society for Medical Oncology·2009
    Same author

    Efficacy and tolerability of amlodipine in the general practice treatment of essential hypertension in an asian multinational population.

    Clinical drug investigation·2008
    Same author

    Social work practice with people with disabilities in the era of disability rights.

    Social work in health care·2001
    Same journal

    Integration of Mendelian Randomization and FAERS Database Analysis Reveals the Association Between Ergotamine and Aortic and Mitral Valve Diseases.

    Journal of cardiovascular pharmacology·2026
    Same journal

    A Comprehensive Review of PCSK9 Inhibitor Therapy.

    Journal of cardiovascular pharmacology·2026
    Same journal

    SGLT2 Inhibitors and Progression of Chronic Kidney Disease in Patients with Elevated Lipoprotein(a): A Real-World Cohort Study.

    Journal of cardiovascular pharmacology·2026
    Same journal

    Aspirin in primary prevention: a case for selective use.

    Journal of cardiovascular pharmacology·2026
    Same journal

    GLP-1 Gene Therapy Trial for Obesity and Type 2 Diabetes: Towards a New Paradigm for Chronic Disease Treatment.

    Journal of cardiovascular pharmacology·2026
    Same journal

    Expert Opinion: Restrictions, Precautions, or Normalcy? Defining Everyday Risk in Patients Treated With IL-1 Blockers for Recurrent Pericarditis.

    Journal of cardiovascular pharmacology·2026
    See all related articles

    Area of Science:

    • Pharmacology
    • Cardiovascular Medicine

    Background:

    • Beta-adrenoceptor antagonists primarily reduce myocardial oxygen consumption by inhibiting sympathoadrenal stimulation.
    • Pure beta blockade can lead to detrimental effects like ventricular dilatation and increased afterload, counteracting therapeutic benefits.

    Purpose of the Study:

    • To evaluate the hemodynamic consequences of pure beta blockade.
    • To highlight the advantages of newer beta-adrenoceptor antagonists with ancillary properties.
    • To introduce celiprolol as a novel beta-blocker with enhanced hemodynamic modulation.

    Main Methods:

    • Review of pharmacological mechanisms of beta-adrenoceptor antagonists.
    • Analysis of hemodynamic effects of pure vs. newer generation beta-blockers.
    • Discussion of celiprolol's unique sympathoadrenal modulation.

    Related Experiment Videos

    Main Results:

    • Pure beta blockade can cause undesirable hemodynamic effects, including impaired cardiac output and increased afterload.
    • Ancillary properties such as positive inotropic activity and vasodilation mitigate these adverse effects.
    • Celiprolol demonstrates a new dimension in beta-blocking therapy through comprehensive sympathoadrenal modulation.

    Conclusions:

    • Newer beta-adrenoceptor antagonists with additional pharmacodynamic properties offer improved hemodynamic profiles.
    • Celiprolol's ability to modulate sympathoadrenal activity provides direct cardiac support and reduces peripheral vasoconstriction.
    • Celiprolol represents a significant advancement in beta-blocking therapy for cardiovascular conditions.